Improved prognosis for neuroblastoma patients
Neuroblastoma is a malignant tumor of early childhood. The course of the disease differs remarkably between individual patients ranging from spontaneous regression to deadly outcome. Scientist of the NGFN now succeeded in developing a prognostic predictor which allows a more precise estimation of the course of the disease. It shall help to anticipate unnecessary treatments and to prevent avoidable cases of recurrence.
more
Breast cancer cells get thwarted by miRNAs
Small regulating micro-RNAs of the miR-200 family are often down regulated during tumor growth. NGFN-scientists could recently show for the first time that this miRNA family can be divided into two clusters. Both have different effects on invasion and apoptosis of breast cancer cells and might be potential targets for future therapies.
more
New insight into the pathogenesis of Parkinson disease
NGFN-scientists of the Hertie Institute for Clinical Brain Research
showed for the first time, that and how the removal of damaged
mitochondria is directed by the two proteins PINK1 and Parkin. A defect
in this removal mechanism might be crucial for the pathogenesis of
Parkinson disease.
more